Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Aspirin and multiple sclerosis.
Multiple sclerosis patients treated with intramuscular IFN-β-1a autoinjector in a real-world setting: prospective evaluation of treatment persistence, adherence, quality of life and satisfaction.
Association of HLA-DRB1*1501 tagging rs3135388 gene polymorphism with multiple sclerosis.
Origin and evolution of deep brain stimulation.
Urinary tract infection in multiple sclerosis: a practical algorithm for a common problem.
Multiple sclerosis: The potassium channel KIR4.1-a potential autoantigen in MS.
Animal models of multiple sclerosis: the good, the bad and the bottom line.
Effects of inoculation with attenuated autologous T cells in patients with rheumatoid arthritis.
[Biomarkers in multiple sclerosis].
Fingolimod Modulates Peripheral Effector and Regulatory T Cells in MS Patients.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53.
Caffeine and alcohol intakes have no association with risk of multiple sclerosis.
Estimated incidence of multiple sclerosis among United States Armed Forces personnel using the Defense Medical Surveillance System.
Systematic localization of common disease-associated variation in regulatory DNA.
Preserved vascular integrity and enhanced survival following neuropilin-1 inhibition in a mouse model of CD8 T cell-initiated CNS vascular permeability.
Neuromyelitis optica lesions may inform multiple sclerosis heterogeneity debate.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
Kinin-mediated inflammation in neurodegenerative disorders.
Cerebrospinal Fluid BAFF and APRIL Levels in Neuromyelitis Optica and Multiple Sclerosis Patients During Relapse.
Heat Shock Protein 70: Roles in Multiple Sclerosis.
Mesenchymal stromal-cell transplants induce oligodendrocyte progenitor migration and remyelination in a chronic demyelination model.
Cannabis and Cannabinoids (PDQ®)
Alemtuzumab: The advantages and challenges of a novel therapy in MS.
Freedom from disease activity in multiple sclerosis.

Pages